[1]张 玲,郭利军△.氢氯吡格雷与替格瑞洛在急性ST段抬高型心肌梗死合并2型糖尿病患者经皮冠状动脉介入治疗中的效果观察[J].陕西医学杂志,2020,49(10):1339-1342.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.037]
　ZHANG Ling,GUO Lijun..Efficacy of hydroclopidogrel and ticagrelor in PCI in patients with acute ST-segment elevation myocardial infarction and type 2 diabetes mellitus[J].,2020,49(10):1339-1342.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.037]
点击复制

氢氯吡格雷与替格瑞洛在急性ST段抬高型心肌梗死合并2型糖尿病患者经皮冠状动脉介入治疗中的效果观察
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年10期
页码:
1339-1342
栏目:
药物与临床
出版日期:
2020-10-05

文章信息/Info

Title:
Efficacy of hydroclopidogrel and ticagrelor in PCI in patients with acute ST-segment elevation myocardial infarction and type 2 diabetes mellitus
作者:
张 玲1; 郭利军2△
1.陕西省汉中市人民医院心血管科(汉中 723000); 2.陕西省汉中市人民医院超声科(汉中 723000)
Author(s):
ZHANG Ling; GUO Lijun.
Department of Cardiology,Hanzhong people's Hospital,Shaanxi Province(Hanzhong 723000)
关键词:
急性ST段抬高型心肌梗死;  2型糖尿病;  经皮冠状动脉介入术;  氢氯吡格雷;  替格瑞洛
Keywords:
Acute ST-segment elevation myocardial infarction;  Type 2 diabetes;  Percutaneous coronary intervention;  Hydroclopidogrel;  Ticagrelor
分类号:
R541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2020.10.037
文献标志码:
A
摘要:
目的:研究氢氯吡格雷与替格瑞洛在急性ST段抬高型心肌梗死合并2型糖尿病患者经皮冠状动脉介入术(PCI)治疗中的效果。方法:纳入98例急性ST段抬高型心肌梗死合并2型糖尿病患者展开研究,按照随机数字表法分为两组,对照组49例应用氢氯吡格雷治疗,观察组49例予以替格瑞洛治疗。将两组的TIMI分级情况、血小板功能、血清炎性因子水平、肱动脉内皮依赖性舒张功能(FMD)、血清内皮素-1(ET-1)、组织型纤溶酶原激活物水平(tPA)、心功能指标、心血管不良事件发生情况进行比对。结果:观察组患者的冠脉再通率高于对照组,治疗后的血小板反应单位(PRU)、血小板计数(MAR)以及血清炎性因子水平低于对照组,差异具有统计学意义(P<0.05); 观察组患者治疗后的FMD、tPA以及左室射血分数(LVEF)高于对照组,ET-1水平以及左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)低于对照组,心血管不良事件发生率低于对照组,差异具有统计学意义(P<0.05)。结论:在急性ST段抬高型心肌梗死合并2型糖尿病患者PCI治疗中应用替格瑞洛的有效性和安全性高于氢氯吡格雷,更有利于改善心肌灌注、血管内皮功能以及心功能,可降低炎症血清炎性因子水平和血小板聚集率,减少心血管不良事件的发生。
Abstract:
Objective:To investigate the efficacy of hydroclopidogrel and ticagrelor in PCI in patients with acute ST-segment elevation myocardial infarction and type 2 diabetes.Methods:A total of 98 patients with acute ST-elevation myocardial infarction and type 2 diabetes were selected and divided into two groups according to the random number table method.49 patients in the control group were treated with hydroclopidogrel,and 49 patients in the observation group were treated with ticagrelor.TIMI grading,platelet function,levels of serum inflammatory factors,brachial flow mediated dilatation(FMD),serum endotherin-1(ET-1),tissue plasminogen activator(tPA)level,cardiac function indicators,and cardiovascular adverse events were compared between the two groups.Results:The rate of coronary recanulation in the observation group was higher than that of the control group,and the levels of PRU,MAR and levels of serum inflammatory factors after treatment were lower than those of the control group,with statistically significant differences(P<0.05).FMD,tPA and LVEF in the observation group after treatment were higher than those in the control group,ET-1 level,LVEDD,LVESD and the incidence of cardiovascular adverse events were lower than those in the control group,with statistically significant differences(P<0.05).Conclusion:The efficacy and safety of ticagrelor in PCI treatment for patients with acute ST-segment elevation myocardial infarction and type 2 diabetes are higher than hydroclopidogrel,and it is more conducive to improving myocardial perfusion,vascular endothelial function and cardiac function,Can reduce serum inflammatory factor levels and platelet aggregation rate,reduce the occurrence of cardiovascular adverse events.

参考文献/References:

[1] 梁舒镇,刘成杰,欧构裕.替格瑞洛联合急诊PCI治疗急性心肌梗死的疗效观察[J].临床医学工程,2020,27(7):887-888.
[2] 高 翔,郑文成,王兆翔,等.替格瑞洛治疗急性心肌梗死经皮冠状动脉介入术后的不良反应及影响因素[J].中国慢性病预防与控制,2020,28(6):458-462.
[3] 崔常贺.替格瑞洛与氯吡格雷治疗急性心肌梗死PCI术后的疗效观察[J].首都食品与医药,2020,27(10):58.
[4] 丁 琦.替格瑞洛对急性ST段抬高型心肌梗死患者PCI术后心功能指标及预后的影响[J].中国医学创新,2020,17(8):23-26.
[5] 林璨璨,戴文龙,何东方,等.替格瑞洛片在氯吡格雷抵抗急性心肌梗死患者经皮冠状动脉介入术后抗血小板治疗中的临床研究[J].中国临床药理学杂志,2020,36(3):221-223,233.
[6] 杨 菊.替格瑞洛联合氯吡格雷对急性ST段抬高型心肌梗死的临床疗效研究[J].基层医学论坛,2020,24(4):516-517.
[7] 许宇飞,邱经纬,管海华.氯吡格雷与替格瑞洛治疗急性心肌梗死患者的疗效[J].医疗装备,2019,32(24):106-107.
[8] 刘东伟,刘再宇,白冰洁,等.替格瑞洛配合急诊PCI治疗急性心肌梗死的效果和安全性观察[J].解放军预防医学杂志,2019,37(12):11-12.
[9] 姜东伟,马腾飞.替格瑞洛与氯吡格雷对急性ST段抬高心肌梗死患者PCI术后心肌保护作用的比较[J].河南医学研究,2019,28(22):4102-4104.
[10] 程志刚,谢民民.氯吡格雷或替格瑞洛治疗急性ST段抬高型心肌梗死患者的临床研究[J].中国临床药理学杂志,2019,35(21):2661-2664.
[11] 刘忠明,刘志阳.替格瑞洛与氯吡格雷对ST段抬高急性心肌梗死患者PCI术后炎症因子和预后的影响[J].武汉大学学报:医学版,2019,40(6):1013-1016.
[12] 白 杰.替格瑞洛对比氯吡格雷在行经皮冠状动脉介入治疗急性ST段抬高型心肌梗死中的临床疗效观察[D].天津:天津医科大学,2019.
[13] 郭 晶,高道明.替格瑞洛和氯吡格雷在急性心肌梗死病人溶栓后PCI治疗中的疗效与安全性分析[J].中西医结合心脑血管病杂志,2019,17(8):1238-1241.

相似文献/References:

[1]戴雨濛,张薇薇,孙梦雯△.中老年2型糖尿病患者尿白蛋白/肌酐与认知功能障碍相关性研究[J].陕西医学杂志,2020,49(3):325.
　DAI Yumeng,ZHANG Weiwei,SUN Mengwen..Correlation between urine albumin-creatinine ratio and cognitive dysfunction in middle-aged and elderly patients with type 2 diabetes mellitus[J].,2020,49(10):325.
[2]杨亚锋,王 萍△,王 利,等.2型糖尿病合并腹型肥胖男性患者胰岛素抵抗与内脏脂肪面积相关性研究*[J].陕西医学杂志,2020,49(6):717.[doi:DOI:10.3969/j.issn.10007377.2020.06.019]
[3]夏旭东,贾凯侠△.首次急性ST段抬高型心肌梗死行经皮冠状动脉介入术后心动过缓发生情况及危险因素分析[J].陕西医学杂志,2020,49(10):1303.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.027]
[4]梁 影,石秀芳.血管内皮生长因子和脂蛋白相关磷脂酶A2在脑梗死合并2型糖尿病患者中的表达及意义[J].陕西医学杂志,2020,49(12):1620.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.021]
　LIANG Ying,SHI Xiufang..Expression and significance of VEGF and Lp-PLA2 in patients with type 2 diabetes mellitus complicated with cerebral infarction[J].,2020,49(10):1620.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.021]
[5]张 菁,姚 蔚,张进安,等.沙格列汀联合前列地尔治疗老年糖尿病肾病临床评价*[J].陕西医学杂志,2020,49(12):1657.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.032]
　ZHANG Jing,YAO Wei,ZHANG Jin'an,et al.Clinical evaluation of saxagliptin combined with alprostadil in treatment of elderly diabetic nephropathy[J].,2020,49(10):1657.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.032]
[6]马 明,谢华宁,张军茹.达格列净治疗2型糖尿病合并慢性心力衰竭临床疗效观察[J].陕西医学杂志,2021,50(1):93.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.025]
[7]谢倩倩,高秀秋,张 超.慢性牙周炎合并2型糖尿病患者龈沟液内脂素水平检测及临床意义[J].陕西医学杂志,2021,50(2):233.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.027]
　XIE Qianqian,GAO Xiuqiu,ZHANG Chao.Expression level and clinical significance of visfatin in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus[J].,2021,50(10):233.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.027]
[8]周 蒨,董 萍,陈 真,等.记忆策略训练对老年2型糖尿病患者认知功能、记忆功能及生活质量的影响[J].陕西医学杂志,2021,50(3):301.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.011]
　ZHOU Qian,DONG Ping,CHEN Zhen,et al.Effect of memory strategy training on cognitive function,memory function and quality of life in elderly patients with type 2 diabetes[J].,2021,50(10):301.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.011]
[9]南飞宁.2型糖尿病患者尿白蛋白水平与黄斑中心凹无血管区域面积及微血管密度相关性分析[J].陕西医学杂志,2021,50(3):312.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.014]
[10]姜 育,张 洁,陈 群,等.心外膜脂肪组织厚度对2型糖尿病合并冠心病患者血管事件发生的预测价值[J].陕西医学杂志,2021,50(5):542.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.007]
　JIANG Yu,ZHANG Jie,CHEN Qun,et al.Value of epicardial adipose tissue thickness in predicting the occurrence of vascular events in patients with type 2 diabetes and coronary heart disease[J].,2021,50(10):542.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.007]

更新日期/Last Update: 2020-10-10